Advertisement
Screener

KURA ONCOLOGY, INC. (KURA) Form D

KURA ONCOLOGY, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-02-05: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2024-01-26; Total offering amount $150,000,808.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-02-05Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2024-01-26$150,000,808$150,000,808$010

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Apnimed, Inc. (APMD)United States$0.899B
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Savara Inc (SVRA)United States$1.044B-9.10
Theravance Biopharma, Inc. (TBPH)$0.885B16.40